NorthWest Biotherapeutics Inc (NWBO)

[mewards]

Woodford Likely sold the Puts knowing that he will keep the stock above 6. Thereby lowering his buy-in costs. It's still considered a hedge. No worries about it going back below 6. No near term risks that I can see, only catalyst for a higher stock price. I appreciate everyone diving into the science of this company but if one wants to keep it simple, follow the money. Follow Woodford.